Clinical Trial Update: Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating contrast-enhanced ultrasonography for detecting renal transplant rejection has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Rejection

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Renal Transplant Rejection | Phase 2 | Status: COMPLETED